High pressure gradient driving venous return
High pressure gradient driving venous return has been studied in 1 paper since 2023: 1 observational study in people. The newest paper, Nov 9, 2023: “Sex-Specific Limitation of Cardiac Capacity During the Adult Life Span: Return to Fundamental Structure and Function”.
1 paper studies it3 findingsUpdated
“In young individuals, "high"-PG increased exercise LVEDV and SV in men (p ≤ .002), but not in women (p ≥ .562), relative to "low"-PG (control condition).”
- 1 lab in 1 country
- 1 finding against
- Humans1
What did studies of High pressure gradient driving venous return find?
2Studies of High pressure gradient driving venous return measured 2 outcomes; the most studied are left ventricular end-diastolic volume (1 study) and left ventricular diastolic function (1).
Left ventricular end-diastolic volume
no changein humans1upin humans1
1 study
Left ventricular end-diastolic volume
no changein humans1upin humans1
High pressure gradient driving venous return has no effect on left ventricular end-diastolic volume in humans.
“In young individuals, "high"-PG increased exercise LVEDV and SV in men (p ≤ .002), but not in women (p ≥ .562), relative to "low"-PG (control condition).”
Human trialrelative to low-PG (control condition)females
The journals of gerontology. Series A, Biological sciences and medical sciences
High pressure gradient driving venous return increases left ventricular end-diastolic volume in humans.
“In young individuals, "high"-PG increased exercise LVEDV and SV in men (p ≤ .002), but not in women (p ≥ .562), relative to "low"-PG (control condition).”
Human trialrelative to low-PG (control condition)males
The journals of gerontology. Series A, Biological sciences and medical sciences
Left ventricular diastolic function
downin humans1
1 study
Left ventricular diastolic function
downin humans1
High pressure gradient driving venous return decreases left ventricular diastolic function in humans.
“In older individuals, "high"-PG did not modify exercise cardiac volumes and reduced LV diastolic function (p ≤ .049).”
Human trial
The journals of gerontology. Series A, Biological sciences and medical sciences